HBsAg Lateral Flow Assay kit in human serum/plasma.
- UID
- MFG/IVD/2020/000053_2b20db1cf092e0d87057bf1b347f07a3_9afdbebbf34033ccee49a8ac6e1a4c7d
- Device class
- Class D
- Brand name
- HBsAg ELISA Kit, Labsystems Diagnostics
- License holder
- Trivitron Healthcare Pvt. Ltd
- Approving authority
- Central Drug Standard Control Organisation, South Zone
- Product information
- BiocardTM HBsAg Rapid Test is a, Immunochromatographic assay for the visual detection of Hepatitis B surface antigen (HBsAg ELISA Kit, Labsystems Diagnostics ) in serum or plasma. It is used as an aid in the diagnosis of Hepatitis B infection. The BIOCARDTM HBsAg Test is based on the principle of sandwich Immunochromatographic assay for determination of HBsAg in serum or plasma. This one step test is very sensitive and only takes 5-20 minutes. Test results can be read visually without any instrument
HBsAg Lateral Flow Assay kit in human serum/plasma. is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000053_2b20db1cf092e0d87057bf1b347f07a3_9afdbebbf34033ccee49a8ac6e1a4c7d. This device is marketed under the brand name HBsAg ELISA Kit, Labsystems Diagnostics . The license holder is Trivitron Healthcare Pvt. Ltd, and it is classified as Device Class Class D. The approving authority is Central Drug Standard Control Organisation, South Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.